Some researchers associate decreased CA9 expression in patients with poor prognosis with the activation of AKT and mTOR pathways, which makes further tumor growth less dependent on hypoxia and shifts it to an alternative pathway [32]. This evidence concerns the gene AKT1 and neoplasm.